Key Facts Surrounding This News Item
- BFRA had returned 0.00% year-to-date leading up to today’s news, versus a -0.57% return from the benchmark S&P 500 during the same period.
More Info About Biofrontera AG (BFRA)
Biofrontera AG, a biopharmaceutical company, primarily focuses on the discovery, development, and distribution of dermatological drugs and dermatologically tested cosmetics for the treatment and care of diseased skin. Biofrontera AG was founded in 1997 and is based in Leverkusen, Germany. View our full BFRA ticker page with ratings, news, and more.